Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study (Q30627430)

13 October 2017

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study (English)

1 reference

13 October 2017

0 references

12

Robert A Rosenheck

1 reference

13 October 2017

6

Jean Addington

1 reference

13 October 2017

13

Joanne Severe

1 reference

13 October 2017

4

Christoph U Correll

1 reference

13 October 2017

17

John M Kane

1 reference

13 October 2017

Delbert G Robinson

1

1 reference

13 October 2017

Nina R Schooler

2

1 reference

13 October 2017

Majnu John

3

1 reference

13 October 2017

Patricia Marcy

5

1 reference

13 October 2017

Mary F Brunette

7

1 reference

13 October 2017

Sue E Estroff

8

1 reference

13 October 2017

Kim T Mueser

9

1 reference

13 October 2017

David Penn

10

1 reference

13 October 2017

James Robinson

11

1 reference

13 October 2017

Amy Goldstein

14

1 reference

13 October 2017

Susan Azrin

15

1 reference

13 October 2017

Robert Heinssen

16

1 reference

13 October 2017

language of work or name

English

0 references

publication date

4 December 2014

1 reference

American Journal of Psychiatry

13 October 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 October 2017

172

1 reference

13 October 2017

3

1 reference

13 October 2017

237-248

1 reference

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Changes over time and disparities in schizophrenia treatment quality

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Pharmacological treatments for first-episode schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Gender differences in the prescribing of antipsychotic drugs

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Racial disparities in antipsychotic prescription patterns for patients with schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Targeted intervention to improve monitoring of antipsychotic-induced weight gain and metabolic disturbance in first episode psychosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Clinical practice guidelines. Treatment of schizophrenia.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4358323

Variable selection and Bayesian model averaging in case-control studies

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25727536

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25727536

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1176/APPI.AJP.2014.13101355

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

25727536

1 reference